The past and future of ‘reported outcomes’ in studies on chemotherapy neuropathy

por Beutler, A S, Majithia, N, Loprinzi, C L
Publicado en Ann Oncol (2017)

Fosaprepitant-induced Phlebitis: A Focus on Patients receiving Doxorubicin/Cyclophosphamide therapy

por Leal, A. D., Kadakia, K. C., Looker, S., Hilger, C., Sorgatz, K., Anderson, K., Jacobson, A., Grendahl, D., Seisler, D., Hobday, T., Loprinzi, C. L.
Publicado 2014

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance)

por Dueck, A. C., Singh, J., Atherton, P., Liu, H., Novotny, P., Hines, S., Loprinzi, C. L., Perez, E. A., Tan, A., Burger, K., Zhao, X., Diekmann, B., Sloan, J. A.
Publicado en Osteoporos Int (2015)

A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB)

por Loprinzi, C. L., Dueck, A. C., Khoyratty, B. S., Barton, D. L., Jafar, S., Rowland, K. M., Atherton, P. J., Marsa, G. W., Knutson, W. H., Bearden, J. D., Kottschade, L., Fitch, T. R.
Publicado 2009

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population(†)

por Renfro, L. A., Grothey, A., Kerr, D., Haller, D. G., André, T., Van Cutsem, E., Saltz, L., Labianca, R., Loprinzi, C. L., Alberts, S. R., Schmoll, H., Twelves, C., Yothers, G., Sargent, D. J., Sargent, D.J., Green, E., Grothey, A., Alberts, S.R., Shi, Q., Renfro, L.A., Yothers, G., O'Connell, M.J., Wolmark, N., de Gramont, A., Gray, R., Kerr, D., Haller, D.G., Guthrie, K., Buyse, M., Labianca, R., Seitz, J.F., O'Callaghan, C.J., Francini, G., Catalano, P.J., Blanke, C.D., Andre, T., Goldberg, R.M., Benson, A., Twelves, C., Sirzen, F., Cisar, L., Van Cutsem, E., Saltz, L.
Publicado en Ann Oncol (2015)